AI News about pharmaceutical pricing

Healthcare & Life Sciences: Drug Pricing Digest — Number 69

Drug Pricing Reform: Latest Healthcare Policy Updates The Drug Pricing and Market Access team monitors evolving healthcare legislation affecting the Medicaid Drug Rebate Program, 340B Program, and Medicare. Recent developments in drug pricing reform and state-level healthcare laws continue reshaping market access strategies. These regulatory changes significantly impact pharmaceutical pricing and patient affordability nationwide.